Premium
Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline‐like drugs in anaesthetized rats
Author(s) -
Wang LiGang,
Zeng Jun,
Yuan WenJun,
Su DingFeng,
Wang WeiZhong
Publication year - 2007
Publication title -
experimental physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.925
H-Index - 101
eISSN - 1469-445X
pISSN - 0958-0670
DOI - 10.1113/expphysiol.2007.037861
Subject(s) - imidazoline receptor , cnqx , kainate receptor , ampa receptor , rostral ventrolateral medulla , chemistry , nmda receptor , clonidine , pharmacology , moxonidine , glutamate receptor , medicine , endocrinology , agonist , receptor , medulla oblongata , central nervous system
The depressor mechanism of imidazoline‐like drugs is believed to result from activation of I 1 ‐imidazoline receptors (I 1 R) and/or α 2 ‐adrenoceptors within the central nervous system, which are associated with the glutamatergic system. The rostral ventrolateral medulla (RVLM) has been recognized as a specific target area that mediates the depressor action of imidazoline‐like drugs. The objective of this study was to determine the comparative effects of blockade of the central glutamate receptor subtypes N ‐methyl‐ d ‐aspartate (NMDA) or α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA)/kainate on the cardiovascular actions of imidazoline‐like drugs (clonidine and moxonidine) in anaesthetized rats. Intracerebroventricular ( i.c.v .) injection of the NMDA receptor antagonist MK801 or the AMPA/kainate receptor antagonist 6‐cyano‐7‐nitroquinoxaline‐2,3‐dione (CNQX) produced similar reductions in blood pressure (BP) and heart rate (HR) to those induced by i.c.v . injection of clonidine. Intracerebroventricular injection of the glutamate receptor antagonist kynurenic acid not only abolished clonidine‐induced hypotension and bradycardia but converted the responses to a pressor action and tachycardia. Unilateral injection of MK801 or CNQX into RVLM significantly attenuated intra‐RVLM clonidine‐induced decreases in BP and HR. We also found that unilateral injection of a selective I 1 R agonist, moxonidine, significantly decreased BP and HR, which were also attenuated to a similar extent by prior injection of MK801 or CNQX. In conclusion, these data show that blockade of central (RVLM) NMDA and AMPA/kainate receptors produces similar attenuation of the decrease in BP and HR induced by clonidine or moxonidine. It is suggested that both NMDA and AMPA/kainate receptors are involved in the cardiovascular inhibition produced by imidazoline‐like drugs, which is probably at least partly dependent on an I 1 R mechanism in the RVLM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom